Alkali-Stabilized Protein A Chromatography Matrix
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current affinity separation matrices for immunoglobulins are unstable in alkaline environments, leading to decreased binding capacity and efficiency in storage, particularly when stored in sodium hydroxide solutions, which are harsh for proteinaceous ligands.
Innovation Solution
A method involving alkali-stabilized Protein A domains, specifically mutants of Staphylococcus Protein A, covalently coupled to porous supports, where the separation matrix is permeated with an aqueous alkali metal hydroxide solution for storage, maintaining stability and binding capacity over extended periods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If conventional protein A-based separation matrices are stored in sodium hydroxide solutions, then storage stability is improved, but binding capacity deteriorates due to ligand instability at high pH
Solution Approach 1:
The patent applies parameter changes by modifying the amino acid sequence of Protein A domains through site-directed mutagenesis. Specifically, asparagine residues at positions 11, 21, and 52 are mutated to amino acids with higher alkali stability (such as serine, threonine, or amino acids lacking side chain amide groups). This changes the chemical parameters of the ligand to resist alkaline degradation while preserving binding function.
Solution Approach 2:
The patent creates a composite affinity matrix by combining mutated Protein A domains with porous support materials. The engineered protein ligands are covalently coupled to the support, creating a composite material that integrates the stability of the mutated protein with the mechanical properties of the porous support, enabling both storage stability and binding capacity.
2Reliability
If alcohol-based storage solutions are used, then binding capacity is preserved, but safety and disposal difficulty worsen due to flammability
Solution Approach 1:
The patent converts the previously harmful effect of alkaline storage (which caused ligand degradation) into a beneficial storage condition. By engineering alkali-stable Protein A variants, the patent enables storage in alkaline solutions that are now harmless to the ligand. This allows using safe, non-flammable aqueous alkaline solutions instead of flammable alcohols, transforming a harmful chemical environment into a beneficial storage medium.
3Ease of manufacture
If conventional Protein A ligands are used, then manufacturing simplicity is maintained, but storage duration is limited due to alkaline sensitivity
Solution Approach 1:
The patent modifies the amino acid sequence parameters of Protein A domains through site-directed mutagenesis. Specific asparagine residues are mutated to amino acids that resist alkaline hydrolysis, changing the chemical stability parameters of the ligand. This enables long-term storage in alkaline conditions while maintaining the relatively simple manufacturing process of recombinant protein expression and affinity chromatography coupling.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method provides a highly alkali-stable separation matrix with retained dynamic binding capacity, allowing for efficient purification of immunoglobulins and reducing the need for alcohol-based storage solutions, which are flammable and difficult to dispose of.
Implementation Method 1
permeating the separation matrix with a storage liquid comprising at least 50% by volume of an aqueous alkali metal hydroxide solution
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention concerns a method of storing a separation matrix comprising multimers of immunoglobulin-binding alkali-stabilized Protein A domains covalently coupled to a porous support. The method comprises the steps of: a) providing a storage liquid comprising at least 50% by volume of an aqueous alkali metal hydroxide solution; b) permeating the separation matrix with the storage liquid; and c) storing the storage liquid-permeated separation matrix for a storage time of at least days. The alkali-stabilized Protein A domains comprise mutants of a parental Fc-binding domain of Staphylococcus Protein A (SpA), as defined by, or having at least 80% such as at least 90%, 95% or 98% identity to, SEQ ID NO 51 or SEQ ID NO 52, wherein the amino acid residues at positions 13 and 44 of SEQ ID NO 51 or 52 are asparagines and wherein at least the asparagine residue at position 3 of SEQ ID NO 51 or 52 has been mutated to an amino acid selected from the group consisting of glutamic acid, lysine, tyrosine, threonine, phenylalanine, leucine, isoleucine, tryptophan, methionine, valine, alanine, histidine and arginine.